CIS-PLATINUM, DOXORUBICIN, AND METHOTREXATE TREATMENT FOR RECURRENT CERVICAL-CANCER
- 1 January 1985
- journal article
- research article
- Vol. 66 (3) , 410-412
Abstract
A combination of cis-platinum, doxorubicin (Adriamycin) and methotrexate was used to treat 28 patients with recurrent cervical cancer. Seven patients achieved a partial response with a median duration of 10 mo. Two patients achieved a complete response with a median duration of 14 mo. The overall response rate was 32%. Ten patients with stable disease had a median progression-free interval of 4.5 mo. Toxicity was acceptable.This publication has 7 references indexed in Scilit:
- Weekly cis-diamminedichloroplatinum II as induction chemotherapy in recurrent carcinoma of the cervixGynecologic Oncology, 1984
- Cervix carcinoma: Treatment with combination cisplatin and bleomycinGynecologic Oncology, 1983
- Cyclophosphamide, adriamycin, and platinum chemotherapy in treatment of advanced and recurrent cervical carcinomaGynecologic Oncology, 1983
- ADRIAMYCIN-METHOTREXATE COMBINATION CHEMOTHERAPY OF ADVANCED-CARCINOMA OF THE CERVIX - A 3RD LOOK1980
- TREATMENT OF CERVICAL CARCINOMA WITH ADRIAMYCIN COMBINED WITH METHOTREXATE1978
- USE OF ADRIAMYCIN AND METHOTREXATE IN CARCINOMA OF CERVIX - DEVELOPMENT OF A SAFE EFFECTIVE REGIMEN1978
- ADRIAMYCIN-METHOTREXATE COMBINATION CHEMOTHERAPY OF ADVANCED CARCINOMA OF CERVIX - 2ND LOOK1977